108 related articles for article (PubMed ID: 30130141)
1. Generation of Rat Monoclonal Antibodies Against a Deubiquitinase, Ovarian Tumor Domain-Containing Protein 1.
Oikawa D; Shiota M; Goto E; Komakura K; Wanibuchi H; Tokunaga F
Monoclon Antib Immunodiagn Immunother; 2018 Aug; 37(4):180-184. PubMed ID: 30130141
[TBL] [Abstract][Full Text] [Related]
2. Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53.
Piao S; Pei HZ; Huang B; Baek SH
Cell Signal; 2017 May; 33():22-29. PubMed ID: 28216291
[TBL] [Abstract][Full Text] [Related]
3. Development of an OTUD1 ubiquitin variant inhibitor.
Liu Q; Mallette E; Zheng H; Zhang W
Biochem J; 2023 Aug; 480(16):1317-1330. PubMed ID: 37589489
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal Antibody Specific for Ovarian Tumor Domain-Containing Protein 1.
Monoclon Antib Immunodiagn Immunother; 2018 Aug; 37(4):194. PubMed ID: 30161019
[No Abstract] [Full Text] [Related]
5. Pleiotropic Roles of a KEAP1-Associated Deubiquitinase, OTUD1.
Oikawa D; Shimizu K; Tokunaga F
Antioxidants (Basel); 2023 Feb; 12(2):. PubMed ID: 36829909
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7.
Zhang Z; Fan Y; Xie F; Zhou H; Jin K; Shao L; Shi W; Fang P; Yang B; van Dam H; Ten Dijke P; Zheng X; Yan X; Jia J; Zheng M; Jin J; Ding C; Ye S; Zhou F; Zhang L
Nat Commun; 2017 Dec; 8(1):2116. PubMed ID: 29235476
[TBL] [Abstract][Full Text] [Related]
7. Generation of Rat Monoclonal Antibodies Specific for DZIP3.
Oikawa D; Shiota M; Tokunaga F; Wanibuchi H
Monoclon Antib Immunodiagn Immunother; 2018 Jun; 37(3):153-157. PubMed ID: 29812999
[TBL] [Abstract][Full Text] [Related]
8. VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma.
Zhang Q; Li J; Chen Z; Jiang K; Yang K; Huang F; Huang A; Zhang X; Zhang J; Wang H
Cell Oncol (Dordr); 2023 Aug; 46(4):1001-1014. PubMed ID: 36929488
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinase OTUD1 inhibits non-small cell lung cancer progression by deubiquitinating and stabilizing KLF4.
Ma X; Wang L; Shi G; Sun S
Thorac Cancer; 2022 Mar; 13(5):761-770. PubMed ID: 35098684
[TBL] [Abstract][Full Text] [Related]
10. Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders.
Lu D; Song J; Sun Y; Qi F; Liu L; Jin Y; McNutt MA; Yin Y
J Autoimmun; 2018 Nov; 94():156-165. PubMed ID: 30100102
[TBL] [Abstract][Full Text] [Related]
11. The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity.
Song J; Liu T; Yin Y; Zhao W; Lin Z; Yin Y; Lu D; You F
EMBO Rep; 2021 Feb; 22(2):e51162. PubMed ID: 33393230
[TBL] [Abstract][Full Text] [Related]
12. Generation of Rat Monoclonal Antibodies Specific for Human Stromal Cell-Derived Factor-2.
Tanaka M; Shiota M; Koyama M; Nakayama J; Yashiro M; Semba K; Goda N
Monoclon Antib Immunodiagn Immunother; 2020 Feb; 39(1):23-26. PubMed ID: 31916900
[TBL] [Abstract][Full Text] [Related]
13. The deubiquitinase OTUD1 noncanonically suppresses Akt activation through its N-terminal intrinsically disordered region.
Fan G; Wang F; Chen Y; Zheng Q; Xiong J; Lv Q; Wu K; Xiong J; Wei L; Li D; Zhang J; Zhang W; Li F
Cell Rep; 2023 Jan; 42(1):111916. PubMed ID: 36640312
[TBL] [Abstract][Full Text] [Related]
14. Melatonin induces apoptotic cell death through Bim stabilization by Sp1-mediated OTUD1 upregulation.
Woo SM; Seo SU; Min KJ; Kwon TK
J Pineal Res; 2022 Jan; 72(1):e12781. PubMed ID: 34826170
[TBL] [Abstract][Full Text] [Related]
15. The Deubiquitinase OTUD1 Suppresses Secretory Neutrophil Polarization And Ameliorates Immunopathology of Periodontitis.
Song J; Zhang Y; Bai Y; Sun X; Lu Y; Guo Y; He Y; Gao M; Chi X; Heng BC; Zhang X; Li W; Xu M; Wei Y; You F; Zhang X; Lu D; Deng X
Adv Sci (Weinh); 2023 Oct; 10(30):e2303207. PubMed ID: 37639212
[TBL] [Abstract][Full Text] [Related]
16. Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome.
Zhang L; Liu J; Qian L; Feng Q; Wang X; Yuan Y; Zuo Y; Cheng Q; Miao Y; Guo T; Zheng X; Zheng H
PLoS Pathog; 2018 May; 14(5):e1007067. PubMed ID: 29734366
[TBL] [Abstract][Full Text] [Related]
17. Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer.
Chen Y; Qiang Y; Fan J; Zheng Q; Yan L; Fan G; Song X; Zhang N; Lv Q; Xiong J; Wang J; Cao J; Liu Y; Xiong J; Zhang W; Li F
Nat Commun; 2024 Feb; 15(1):1321. PubMed ID: 38351029
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody specific for Dhx9/NDHII/RHA.
Kotani M; Harada A; Odawara J; Azuma M; Okada S; Nishiyama Y; Nakamura M; Tachibana T; Ohkawa Y
Hybridoma (Larchmt); 2010 Jun; 29(3):259-61. PubMed ID: 20569003
[TBL] [Abstract][Full Text] [Related]
19. A rat monoclonal antibody against the chromatin remodeling factor CHD5.
Yoshimura S; Yoshimi T; Ohkawa Y; Azuma M; Tachibana T
Hybridoma (Larchmt); 2010 Feb; 29(1):63-6. PubMed ID: 20199154
[TBL] [Abstract][Full Text] [Related]
20. Generation of a rat monoclonal antibody specific for CHD2.
Harada A; Yoshimura S; Odawara J; Azuma M; Okada S; Nakamura M; Tachibana T; Ohkawa Y
Hybridoma (Larchmt); 2010 Apr; 29(2):173-7. PubMed ID: 20443711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
